Table 1 The top 100 most cited articles on thymoma
From: The 100 most cited papers on thymoma: a bibliometric analysis
Rank | First author | Title | Citation | Publication Year |
|---|---|---|---|---|
1 | Masaoka, A | Follow-up-study of thymomas with special reference to their clinical stages | 1182 | 1981 |
2 | Kondo, K | Therapy for thymic epithelial tumors: A clinical study of 1,320 patients from Japan | 494 | 2003 |
3 | Okumura, M | The World Health Organization histologic classification system reflects the oncologic behavior of thymoma—A clinical study of 273 patients | 393 | 2002 |
4 | Lewis, Je | Thymoma—a clinicopathological review | 370 | 1987 |
5 | Engels, EA | Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies | 322 | 2003 |
6 | Marino, M | Thymoma and thymic carcinoma—relation of thymoma epithelial-cells to the cortical and medullary differentiation of thymus | 317 | 1985 |
7 | Regnard, JF | Prognostic factors and long-term results after thymoma resection: A series of 307 patients | 304 | 1996 |
8 | Koga, K | A review of 79 thymomas—modification of staging system and reappraisal of conventional division into invasive and noninvasive thymoma | 295 | 1994 |
9 | Blumberg, D | Thymoma—a multivariate-analysis of factors predicting survival | 277 | 1995 |
10 | Chen, G | New WHO histologic classification predicts prognosis of thymic epithelial tumors—A clinicopathologic study of 200 thymoma cases from China | 274 | 2002 |
11 | Engels, EA | Epidemiology of Thymoma and Associated Malignancies | 270 | 2010 |
12 | Verley, Jm | Thymoma—a comparative-study of clinical stages, histologic features, and survival in 200 cases | 268 | 1985 |
13 | Maggi, G | Thymoma—results of 241 operated cases | 266 | 1991 |
14 | Marx, A | The 2015 World Health Organization Classification of Tumors of the Thymus Continuity and Changes | 263 | 2015 |
15 | Detterbeck, FC | Thymic tumors | 257 | 2004 |
16 | Strobel, P | Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: A retrospective analysis | 224 | 2004 |
17 | Detterbeck, FC | The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors | 217 | 2014 |
18 | Kondo, K | WHO histologic classification is a prognostic indicator in thymoma | 214 | 2004 |
19 | Curran, Wj | Invasive thymoma—the role of mediastinal irradiation following complete or incomplete surgical resection | 208 | 1988 |
20 | Loehrer, Pj | Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma—final results of an intergroup trial | 204 | 1994 |
21 | Kim, ES | Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report | 204 | 2004 |
22 | Thomas, CR | Thymoma: State of the art | 203 | 1999 |
23 | Detterbeck, FC | The Masaoka-Koga Stage Classification for Thymic Malignancies Clarification and Definition of Terms | 191 | 2011 |
24 | Girard, N | Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(aeuro) | 182 | 2015 |
25 | Quintanillamartinez, L | Thymoma—histologic subclassification is an independent prognostic factor | 178 | 1994 |
26 | Wright, CD | Predictors of recurrence in thymic tumors: Importance of invasion, World Health Organization histology, and size | 174 | 2005 |
27 | Kelleher, P | What is Good's syndrome? Immunological abnormalities in patients with thymoma | 172 | 2003 |
28 | Nakahara, K | Thymoma—results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients | 170 | 1988 |
29 | Falkson, CB | The Management of Thymoma: A Systematic Review and Practice Guideline | 170 | 2009 |
30 | Marx, A | ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting | 168 | 2014 |
31 | Nakagawa, K | Thymoma: A clinicopathologic study based on the new World Health Organization classification | 165 | 2003 |
32 | Fornasiero, A | Chemotherapy for invasive thymoma—a 13-year experience | 161 | 1991 |
33 | Tarr, PE | Infections in patients with immunodeficiency with thymoma (Good syndrome)—Report of 5 cases and review of the literature | 161 | 2001 |
34 | Loehrer, PJ | Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: An intergroup trial | 158 | 1997 |
35 | Venuta, F | Long-term outcome after multimodality treatment for stage III thymic tumors | 152 | 2003 |
36 | Ruffini, E | Recurrence of thymoma: Analysis of clinicopathologic features, treatment, and outcome | 149 | 1997 |
37 | de Jong, WK | Thymic epithelial turnours: A population-based study of the incidence, diagnostic procedures and therapy | 148 | 2008 |
38 | Aarli, Ja | Patients with myasthenia-gravis and thymoma have in their sera igg autoantibodies against titin | 147 | 1990 |
39 | Loehrer, PJ | Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma—An intergroup trial | 142 | 2001 |
40 | Giaccone, G | Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma: A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group | 141 | 1996 |
41 | Kelesidis, T | Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence | 141 | 2010 |
42 | Monden, Y | Recurrence of thymoma—clinicopathological features, therapy, and prognosis | 140 | 1985 |
43 | Pan, CC | KIT (CDII7) is frequently overexpressed in thymic carcinomas but is absent in thymomas | 135 | 2004 |
44 | Sung, YM | F-18-FDG PET/CT of thymic epithelial tumors: Usefulness for distinguishing and staging tumor subgroups | 135 | 2006 |
45 | Masaoka, A | Staging System of Thymoma | 135 | 2010 |
46 | Ishibashi, H | Sex steroid hormone receptors in human thymoma | 133 | 2003 |
47 | Maggi, G | Thymomas—a review of 169 cases, with particular reference to results of surgical-treatment | 133 | 1986 |
48 | Hoffacker, V | Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease | 133 | 2000 |
49 | Venuta, F | Thymoma and thymic carcinoma | 133 | 2010 |
50 | Wilkins, KB | Clinical and pathologic predictors of survival in patients with thymoma | 132 | 1999 |
51 | Vernino, S | Autoantibody profiles and neurological correlations of thymoma | 132 | 2004 |
52 | Macchiarini, P | Neoadjuvant chemotherapy, surgery, and postoperative radiation-therapy for invasive thymoma | 132 | 1991 |
53 | Thomas, A | Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial | 132 | 2015 |
54 | Detterbeck, FC | Clinical value of the WHO classification system of thymoma | 132 | 2006 |
55 | Singhal, S | Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation | 128 | 2003 |
56 | Suster, S | Thymoma, atypical thymoma, and thymic carcinoma—A novel conceptual approach to the classification of thymic epithelial neoplasms | 128 | 1999 |
57 | Lemma, GL | Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma | 127 | 2011 |
58 | Zettl, A | Recurrent genetic aberrations in thymoma and thymic carcinoma | 126 | 2000 |
59 | Sommer, N | Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive t-cells | 124 | 1990 |
60 | Girard, N | Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas | 124 | 2009 |
61 | Rea, F | Chemotherapy and operation for invasive thymoma | 124 | 1993 |
62 | Suster, S | Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma—A clinicopathologic study of 22 cases | 123 | 1996 |
63 | Morgenthaler, Ti | Thymoma | 123 | 1993 |
64 | Scorsetti, M | Thymoma and thymic carcinomas | 123 | 2016 |
65 | Loehrer, PJ | Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: An Eastern Cooperative Oncology Group phase II trial | 121 | 2004 |
66 | Petrini, I | A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors | 120 | 2014 |
67 | Radovich, M | The Integrated Genomic Landscape of Thymic Epithelial Tumors | 120 | 2018 |
68 | Meager, A | Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis | 119 | 2003 |
69 | Tomiyama, N | Anterior mediastinal tumors: Diagnostic accuracy of CT and MRI | 119 | 2009 |
70 | Wilkins, Ew | Role of staging in prognosis and management of thymoma | 118 | 1991 |
71 | Okumura, M | Clinical and functional significance of WHO classification on human thymic epithelial neoplasms—A study of 146 consecutive tumors | 118 | 2001 |
72 | Sadohara, J | Thymic epithelial tumors: Comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas | 118 | 2006 |
73 | Kaira, K | Biologic Correlation of 2-[F-18]-Fluoro-2-Deoxy-D-Glucose Uptake on Positron Emission Tomography in Thymic Epithelial Tumors | 118 | 2010 |
74 | Yamakawa, Y | A tentative tumor-node-metastasis classification of thymoma | 117 | 1991 |
75 | Jeong, YJ | Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? | 117 | 2004 |
76 | Giaccone, G | Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors | 115 | 2011 |
77 | Shelly, S | Thymoma and autoimmunity | 114 | 2011 |
78 | Buckley, C | Mature, long-lived CD4( +) and CD8( +) T cells are generated by the thymoma in myasthenia gravis | 113 | 2001 |
79 | Bernard, C | Thymoma associated with autoimmune diseases: 85 cases and literature review | 113 | 2016 |
80 | Willcox, N | Myasthenic and nonmyasthenic thymoma—an expansion of a minor cortical epithelial-cell subset | 112 | 1987 |
81 | Rea, F | Long-term survival and prognostic factors in thymic epithelial tumours | 110 | 2004 |
82 | Kim, DJ | Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors—A clinicopathologic study of 108 patients and literature review | 110 | 2005 |
83 | Gautel, M | Titin antibodies in myasthenia-gravis—identification of a major immunogenic region of titin | 109 | 1993 |
84 | Kondo, K | Lymphogenous and hematogenous metastasis of thymic epithelial tumors | 109 | 2003 |
85 | Katsuya, Y | Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma | 107 | 2015 |
86 | Mygland, A | Ryanodine receptor autoantibodies in myasthenia-gravis patients with a thymoma | 107 | 1992 |
87 | Okumura, M | Results of surgical treatment of thymomas with special reference to the involved organs | 106 | 1999 |
88 | Margaritora, S | Thirty-Five-Year Follow-Up Analysis of Clinical and Pathologic Outcomes of Thymoma Surgery | 106 | 2010 |
89 | Pennathur, A | Comparison of surgical techniques for early-stage thymoma: Feasibility of minimally invasive thymectomy and comparison with open resection | 106 | 2011 |
90 | Marx, A | Thymoma and paraneoplastic myasthenia gravis | 106 | 2010 |
91 | Pescarmona, E | Analysis of prognostic factors and clinicopathological staging of thymoma | 104 | 1990 |
92 | Evoli, A | Thymoma in patients with MG—Characteristics and long-term outcome | 104 | 2002 |
93 | Girard, N | Thymoma A Focus on Current Therapeutic Management | 104 | 2009 |
94 | Ogawa, K | Postoperative radiotherapy for patients with completely resected thymoma—A multi-institutional, retrospective review of 103 patients | 103 | 2002 |
95 | Ruffini, E | Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database | 103 | 2014 |
96 | Chalabreysse, L | Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis—A retrospective study of 90 tumors | 102 | 2002 |
97 | Lee, EK | Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma | 102 | 1998 |
98 | Bodner, J | Early experience with robot-assisted surgery for mediastinal masses | 100 | 2004 |
99 | Wright, CD | Induction chemoradiotherapy followed by resection for locally advanced masaoka stage III and IVA thymic tumors | 99 | 2008 |
100 | Davenport, E | The role of surgery in the management of thymoma: A systematic review | 97 | 2008 |